Target and Lead Identification for TB Drug Discovery to deliver novel hits and leads for optimization to TB drug candidates of Target and Lead Identification for TB Drug Discovery from 10/18/2022 to 10/31/2025. Grantee name: Texas A&M Research Foundation.